Table 1. Characteristics of the patients (n = 94).
| Median age, y (range) | 56 (20–88) |
| Median observation time of patients alive, Mo (range) | 29 (2–145) |
| FIGO stage, n (%) | |
| I | 40 (42.6) |
| II | 5 (5.3) |
| III | 33 (35.1) |
| IV | 16 (17.0) |
| Histologic subtype, n (%) | |
| Serous adenocarcinoma | 34 (36.2) |
| Clear cell carcinoma | 20 (21.3) |
| Endometrial adenocarcinoma | 11 (11.7) |
| Mucinous adenocarcinoma | 16 (17.0) |
| Unclassified adenocarcinoma | 4 (4.3) |
| Mixed epithelial tumors | 3 (3.2) |
| Carcinosarcoma | 2 (2.1) |
| Immature teratoma | 2 (2.1) |
| Undifferentiated carcinoma | 1 (1.1) |
| Others | 1 (1.1) |
| Residual tumor (cm), n (%) | |
| ≦1 | 60 (63.8) |
| >1 | 32 (34.0) |
| unknown | 2 (2.1) |
| Chemotherapy, n (%) | |
| Taxane/platinum | 61 (64.9) |
| Others | 9 (9.6) |
| None | 24 (25.5) |